Drug LitigationThe Numbers Behind Transvaginal Mesh Complications

February 21, 2013

The Food and Drug Administration (FDA) has recently published troubling statistics about transvaginal mesh (TVM) procedures. Simply put, the failure rate for this medical device is troublingly high, suggesting that the maker and marketer of this health device may have been irresponsible with their designs or advertisements.

 

In any given year, roughly 500,000 women undergo TVM procedures, usually for either pelvic organ prolapse (POP) or stress urinary incontinence (SUI). Although the majority of these patients experience no problem, a large and growing minority report adverse events, such as pain, discomfort, and infection. Many are required to see a medical professional for follow-up procedures and care.

 

Are you a TVM patient who has suffered these kinds of adverse events? You should speak with a dedicated attorney at the law firm of Nachawati Law Group to find out more information about how this medical reality might impact your legal rights. With years of experience in this important area of the law, we know how to advise you.  

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.